Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein transport protein Sec61 subunit alpha isoform 1 (Sec61α1) is the central, pore-forming component of the Sec61 translocon complex, a universally conserved heterotrimeric assembly located in the endoplasmic reticulum (ER) membrane. It serves as the primary gateway for the entry of nearly all secretory and most membrane proteins into the ER, facilitating both co-translational and post-translational translocation. Beyond its role in protein transport, Sec61α1 functions as a passive calcium leak channel, contributing to cellular calcium homeostasis and signaling. Mutations in the SEC61A1 gene are associated with various pathologies, including autosomal dominant tubulointerstitial kidney disease and severe congenital neutropenia, while its upregulation is linked to several cancers. Pharmacological targeting of Sec61α1 with small-molecule inhibitors like KZR-261 and mycolactone offers a novel therapeutic strategy by blocking the biogenesis of specific oncogenic or inflammatory proteins, thereby inducing ER stress and apoptosis in target cells. However, the essential nature of the translocon in cellular proteostasis presents significant challenges in achieving therapeutic selectivity and managing potential systemic toxicity.
Inhibition of protein translocation into the endoplasmic reticulum by binding to the Sec61 channel and stabilizing the plug domain in a closed state, thereby preventing substrate polypeptide insertion.
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein transport protein Sec61 subunit alpha isoform 1 (SEC61A1) (SEC61A1).